한글목차

설파살라진 시장은 2025년 22억 4,000만 달러, 2032년에는 33억 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 5.7%를 나타낼 전망입니다.

설파살라진은 류마티스 관절염, 궤양성 대장염, 크론병과 같은 염증성 장 질환의 치료에 주로 사용되는 질병 변형 항류마티스제(DMARD)로 분류되는 약물입니다. 이 약은 설파피리딘과 5-아미노살리실산(5-ASA)의 독특한 조합으로 알려져 있으며, 둘 다 치료 효과에 기여하는 것으로 알려져 있습니다. 류마티스 관절염에서 설파살라진은 면역계 반응을 억제하고 염증을 완화하며 관절의 통증과 부종을 완화합니다. 이 만성 자가면역질환의 증상과 진행을 관리하기 위한 종합적인 치료 계획의 일환으로 처방되는 경우가 많습니다. 염증성 장 질환은 소화관의 만성 염증과 관련이 있으며, 설파살라진의 항염증 작용은 궤양성 대장염과 크론병과 관련된 증상을 치료하는 데 도움이 될 수 있습니다. 설파살라진의 5-ASA 성분은 소화관 내 항염증 작용에 중요한 역할을 하는 것으로 알려져 있습니다. 설파살라진은 보통 경구 투여되며, 그 효과가 나타나기까지 시간이 걸리는 경우가 많습니다. 다른 약물과 마찬가지로 부작용이 있을 수 있기 때문에 의료 전문가가 주의 깊게 모니터링해야 합니다. 설파살라진은 특정 염증성 질환에 널리 사용되지만, 다양한 작용기전으로 인해 이러한 질환의 의학적 관리에 있어 귀중한 치료 옵션으로 남아 있습니다.

시장 역학

설파살라진 시장의 성장은 몇 가지 중요한 요인의 영향을 받습니다. 첫째, 자가면역질환과 소화기 질환의 전 세계 유병률 증가가 중요한 촉진요인으로 작용하고 있습니다. 이러한 질환에 대한 인식과 진단이 증가함에 따라 설파살라진 및 유사 약물에 대한 수요가 확대될 가능성이 높습니다. 둘째, 인구 고령화, 특히 신흥국 시장에서의 인구 고령화가 시장 확대에 기여하고 있습니다. 노인들은 염증성 질환에 걸리기 쉬워 설파살라진과 같은 장기적인 관리 및 치료 옵션에 대한 필요성이 증가합니다. 셋째, 제약 업계에서 진행 중인 연구 개발은 설파살라진의 보다 진보되고 효과적인 제형을 도입하여 시장 성장을 더욱 촉진할 수 있습니다.

그러나 시장은 대체 치료법의 가용성, 설파살라진에 따른 부작용 가능성 등의 문제에 직면할 수 있습니다. 의료 시스템의 규제 변화와 가격 압력은 시장 역학에 영향을 미칠 수 있습니다.

본 보고서의 주요 특징

• 세계의 설파살라진(Sulfasalazine) 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 CAGR을 조사 분석하여 전해드립니다.
• 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 세계 설파살라진(Sulfasalazine) 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등 다양한 매개 변수를 기반으로 작성되었습니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• "세계 설파살라진 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 설파살라진 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 분석 목적과 전제조건

• 분석 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매 및 승인
• PEST 분석
• Porter의 Five Forces 분석
• 인수합병(M&A) 시나리오

제4장 세계의 설파살라진 시장 : 신형 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 설파살라진 시장 : 제품 유형별(2020-2032년)

• 제네릭 설파살라진
• 브랜드 설파살라진

제6장 세계의 설파살라진 시장 : 용도별(2020-2032년)

• 류마티스 관절염
• 크론병
• 궤양성 대장염
• 기타 염증성 장질환

제7장 세계의 설파살라진 시장 : 최종사용자별(2020-2032년)

• 병원
• 클리닉
• 외래수술센터(ASC)
• 기타(학술연구기관 등)

제8장 세계의 설파살라진 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카

제9장 경쟁 구도

• Pfizer Inc.
• Teva Pharmaceuticals USA, Inc.
• Ipca Laboratories Ltd
• Novalab Healthcare
• Dr. Reddy's Laboratories, Inc.
• Actus Healthcare
• Medisoft Pharma
• OVERSEAS HEALTH CARE
• Astonea Labs Private Limited
• Fibovil Pharmaceuticals Pvt Ltd

제10장 섹션

• 분석 방법
• 출판사에 대해

영문목차

Sulfasalazine Market is estimated to be valued at USD 2.24 Bn in 2025 and is expected to reach USD 3.3 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032.

Sulfasalazine is a medication that falls under the category of disease-modifying antirheumatic drugs (DMARDs) and is primarily used in the treatment of inflammatory conditions, particularly rheumatoid arthritis and inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. The drug is known for its unique combination of sulfapyridine and 5-aminosalicylic acid (5-ASA), both of which contribute to its therapeutic effects. In the context of rheumatoid arthritis, sulfasalazine works by suppressing the immune system's response, mitigating inflammation, and helping to alleviate joint pain and swelling. It is often prescribed as part of a comprehensive treatment plan to manage the symptoms and progression of this chronic autoimmune disorder. Inflammatory bowel diseases involve chronic inflammation of the digestive tract, and sulfasalazine's anti-inflammatory properties are beneficial in treating symptoms associated with ulcerative colitis and Crohn's disease. The 5-ASA component of sulfasalazine is believed to play a key role in this anti-inflammatory action within the gastrointestinal tract. Sulfasalazine is typically administered orally, and its effectiveness often requires some time to become evident. Like any medication, it may have potential side effects, and its use is closely monitored by healthcare professionals. While widely used for specific inflammatory conditions, sulfasalazine's diverse mechanisms of action continue to make it a valuable therapeutic option in the medical management of these diseases.

Market Dynamics

The growth of the sulfasalazine market is influenced by several key factors. First, the rising incidence of autoimmune and gastrointestinal disorders globally is a significant driver. As awareness and diagnosis of these conditions increase, the demand for sulfasalazine and similar medications is likely to grow. Second, the aging population, particularly in developed countries, contributes to the expansion of the market. Older individuals are more susceptible to inflammatory diseases, increasing the need for long-term management and treatment options like sulfasalazine. Third, ongoing research and development in the pharmaceutical industry may lead to the introduction of more advanced and effective formulations of sulfasalazine, further propelling market growth.

However, the market may also face challenges, such as the availability of alternative treatment options and the potential for side effects associated with sulfasalazine. Regulatory changes and pricing pressures in healthcare systems can impact market dynamics.

Key features of the study:

• This report provides in-depth analysis of the global sulfasalazine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global sulfasalazine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceuticals USA, Inc., Ipca Laboratories Ltd, Novalab Healthcare, Dr. Reddy's Laboratories, Inc., Actus Healthcare, Medisoft Pharma, OVERSEAS HEALTH CARE, Astonea Labs Private Limited. and Fibovil Pharmaceuticals Pvt Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global sulfasalazine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sulfasalazine market

Detailed Segmentation:

• Sulfasalazine Market, By Product Type:
  • Generic Sulfasalazine
  • Branded Sulfasalazine
• Sulfasalazine Market, By Application:
  • Rheumatoid Arthritis
  • Crohn's Disease
  • Ulcerative Colitis
  • Other Inflammatory Bowel Diseases
• Sulfasalazine Market, By End User:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others (Academic and Research Institutes etc.)
• Sulfasalazine Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Pfizer Inc.
  • Teva Pharmaceuticals USA, Inc.
  • Ipca Laboratories Ltd
  • Novalab Healthcare
  • Reddy's Laboratories, Inc.
  • Actus Healthcare
  • Medisoft Pharma
  • OVERSEAS HEALTH CARE
  • Astonea Labs Private Limited
  • Fibovil Pharmaceuticals Pvt Ltd

Table of Content

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Global Sulfasalazine Market, By Product Type
  • Market Global Sulfasalazine Market, By Application
  • Market Global Sulfasalazine Market, By End user
  • Market Global Sulfasalazine Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising awareness and diagnoses
  • Competition from advanced therapies
  • Combination therapies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Sulfasalazine Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Sulfasalazine Market, By Product Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Generic Sulfasalazine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Branded Sulfasalazine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Sulfasalazine Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Rheumatoid Arthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Crohn's Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Ulcerative Colitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other Inflammatory Bowel Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Sulfasalazine Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others (Academic and Research Institutes etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Sulfasalazine Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceuticals USA, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ipca Laboratories Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novalab Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Dr. Reddy's Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Actus Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Medisoft Pharma
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• OVERSEAS HEALTH CARE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Astonea Labs Private Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Fibovil Pharmaceuticals Pvt Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us